Two Sigma Advisers’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $46K | Sell |
|
|||||
|
2024
Q4 | $79.6K | Sell |
|
|||||
|
2024
Q3 | $118K | Sell |
|
|||||
|
2024
Q2 | $189K | Buy |
|
|||||
|
2024
Q1 | $895K | Buy |
|
|||||
|
2023
Q4 | $266K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $56.9K | Sell |
|
|||||
|
2022
Q4 | $89.8K | Sell |
|
|||||
|
2022
Q3 | $214K | Buy |
|
|||||
|
2022
Q2 | $217K | Buy |
|
|||||
|
2022
Q1 | $80K | Sell |
|
|||||
|
2021
Q4 | $247K | Sell |
|
|||||
|
2021
Q3 | $529K | Buy |
|
|||||
|
2021
Q2 | $353K | Buy |
|
|||||
|
2021
Q1 | $364K | Buy |
|